Free Trial

Wellington Wealth Strategies LLC. Sells 1,390 Shares of Accenture plc (NYSE:ACN)

Accenture logo with Computer and Technology background

Wellington Wealth Strategies LLC. lessened its holdings in shares of Accenture plc (NYSE:ACN - Free Report) by 22.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,875 shares of the information technology services provider's stock after selling 1,390 shares during the quarter. Accenture comprises 1.8% of Wellington Wealth Strategies LLC.'s portfolio, making the stock its 15th biggest holding. Wellington Wealth Strategies LLC.'s holdings in Accenture were worth $1,899,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ACN. FPC Investment Advisory Inc. increased its stake in Accenture by 62.2% in the 4th quarter. FPC Investment Advisory Inc. now owns 73 shares of the information technology services provider's stock worth $28,000 after acquiring an additional 28 shares during the last quarter. Kohmann Bosshard Financial Services LLC bought a new stake in Accenture in the 4th quarter worth approximately $30,000. POM Investment Strategies LLC increased its stake in Accenture by 64.2% in the 4th quarter. POM Investment Strategies LLC now owns 87 shares of the information technology services provider's stock worth $31,000 after acquiring an additional 34 shares during the last quarter. Promus Capital LLC bought a new stake in Accenture in the 4th quarter worth approximately $34,000. Finally, Berbice Capital Management LLC bought a new stake in Accenture in the 4th quarter worth approximately $35,000. Institutional investors own 75.14% of the company's stock.

Insider Transactions at Accenture

In other news, COO John F. Walsh sold 2,500 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $325.00, for a total value of $812,500.00. Following the completion of the transaction, the chief operating officer now directly owns 15,882 shares of the company's stock, valued at approximately $5,161,650. The trade was a 13.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Julie Spellman Sweet sold 2,284 shares of the business's stock in a transaction on Friday, April 11th. The stock was sold at an average price of $281.63, for a total value of $643,242.92. Following the completion of the transaction, the chief executive officer now directly owns 9,965 shares of the company's stock, valued at approximately $2,806,442.95. The trade was a 18.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 8,516 shares of company stock valued at $2,507,366. Corporate insiders own 0.02% of the company's stock.

Wall Street Analyst Weigh In

ACN has been the topic of a number of research reports. Morgan Stanley reduced their price objective on Accenture from $380.00 to $372.00 and set an "equal weight" rating on the stock in a research note on Monday, March 17th. Guggenheim reduced their price objective on Accenture from $400.00 to $395.00 and set a "buy" rating on the stock in a research note on Friday, March 21st. Barclays dropped their target price on Accenture from $415.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, March 24th. Stifel Nicolaus dropped their target price on Accenture from $390.00 to $380.00 and set a "buy" rating for the company in a report on Wednesday, February 26th. Finally, Royal Bank of Canada dropped their target price on Accenture from $399.00 to $392.00 and set an "outperform" rating for the company in a report on Friday, March 21st. Seven analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Accenture currently has a consensus rating of "Moderate Buy" and an average price target of $381.76.

View Our Latest Report on Accenture

Accenture Trading Up 0.5%

Shares of NYSE ACN opened at $319.16 on Tuesday. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.17. The business has a fifty day simple moving average of $302.50 and a two-hundred day simple moving average of $340.97. The firm has a market cap of $199.90 billion, a PE ratio of 26.78, a price-to-earnings-growth ratio of 3.23 and a beta of 1.35. Accenture plc has a twelve month low of $275.01 and a twelve month high of $398.35.

Accenture (NYSE:ACN - Get Free Report) last issued its earnings results on Thursday, March 20th. The information technology services provider reported $2.82 earnings per share for the quarter, beating analysts' consensus estimates of $2.81 by $0.01. The business had revenue of $16.70 billion during the quarter, compared to analyst estimates of $16.64 billion. Accenture had a return on equity of 26.91% and a net margin of 11.41%. Accenture's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.77 EPS. Analysts expect that Accenture plc will post 12.73 earnings per share for the current fiscal year.

Accenture Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 10th were given a $1.48 dividend. This represents a $5.92 annualized dividend and a dividend yield of 1.85%. The ex-dividend date was Thursday, April 10th. Accenture's payout ratio is 48.89%.

Accenture Company Profile

(Free Report)

Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.

Recommended Stories

Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture plc (NYSE:ACN - Free Report).

Institutional Ownership by Quarter for Accenture (NYSE:ACN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Accenture Right Now?

Before you consider Accenture, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accenture wasn't on the list.

While Accenture currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines